• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Indonesia·Financial Services·BMRI.JK
Share

PT Bank Mandiri Stocks

IDR 4140Last Updated 24.06.2026

Issuer Rating

5/7
Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

IDR 24.14B

IDR 4140
Key Takeaways

Risk factor

High price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Excellent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

PT Bank Mandiri (Persero) Tbk operates as a leading financial institution, delivering a comprehensive array of banking solutions to both individual and corporate clients. Its extensive operational footprint spans not only Indonesia but also key international markets such as Singapore, Hong Kong, Timor Leste, Shanghai, Malaysia, the United Kingdom, and the Cayman Islands. For its retail customers, the bank offers a diverse range of deposit products, including various savings, current, time, and demand accounts, which are also available in foreign currencies. Additionally, it provides numerous lending options tailored to personal needs, such as motorcycle, housing, and mortgage loans, alongside financing for purposes like education, home renovation, marriage, health, and other specific requirements. Corporate clients benefit from a robust selection of financing facilities, comprising working capital, investment, people's business, syndicated, and micro business loans. Beyond core banking, PT Bank Mandiri also engages in investment services, providing access to mutual funds, stock trading, and bond trading. Its portfolio further extends to insurance products, covering life, health, and general categories, in addition to offering various payment instruments like credit, debit, and corporate cards. The bank embraces digital innovation through its e-banking platforms and digital lending services. Specialized offerings include comprehensive cash management solutions, a full spectrum of trade finance services (encompassing value chain and supply chain management, global and domestic trade, export/import support, standby letters of credit, and bank guarantees), and spot and foreign exchange transactions. Custodial services are also provided, alongside treasury services focused on cash transaction/liquidity management, hedging strategies, and investment products. Furthermore, its trust services encompass roles such as trustee, paying agent, security agent, escrow agent, monitoring agent, and receiving bank. Other key financial services include money transfer, remittance services, and venture capital financing. As of December 31, 2021, PT Bank Mandiri maintained a substantial physical presence, operating 2,609 branches in total. This network was composed of 137 main branch offices, 2,465 sub-branch offices, and 7 overseas branch offices. Complementing its branch network, the company also provided convenience through 13,087 ATM facilities. Established in 1998, the institution's primary headquarters are located in Jakarta, Indonesia.

Company Valuation

Undervalued
6/7

Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, underpriced on P/RIBP. Editor's note: P/CR is

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of BMRI.JK is 5557 and suggests 31.7% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.06.2026 08:00

Alibaba has filed a lawsuit against the Pentagon over allegations of ties to the Chinese military

24.06.2026 07:00

Alphabet will be added to the Dow Jones Blue Chip Index. Its stock price has doubled over the past year

24.06.2026 01:47

The boom in the prediction market has prompted Meta to create its own app — NYT

24.06.2026 01:09

The Nasdaq fell 2%, with volatility hitting a two-year high: a look back at the day's sell-off in the tech sector

24.06.2026 00:50

The dollar rose to its highest level since November: Traders are betting on a Fed rate hike

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026